Periodonitis and Alzheimer's Disease

NCT05189132 | Unknown

• 1 other identifier: University Lisbon
• Study Type: observational
• Target: 134
• Locations: 0 countries
• Sites: N/A

Brief Summary

The main objective of this study is to assess whether Periodontal Disease is more prevalent in adult patients diagnosed with Alzheimer's Disease compared to adult patients without Alzheimer's Disease. The secondary objective is to describe and characterize the microbiological and biochemical profile of adult patients diagnosed with Alzheimer's Disease and compare with adult patients without Alzheimer's Disease.

Conditions

Alzheimer Disease; Periodontitis

Keywords

Alzheimer Disease; Periodontitis

Outcome Measures

Primary Outcomes (7)

• Probing depth

  The probing depth corresponds to the distance from the gingival margin to the bottom of the sulcus or periodontal pocket. Probing depth measurement will be performed at six locations per tooth, three locations per buccal and three locations per lingual/palatal

  Basline

• Clinical attachment level

  The clinical insertion level corresponds to the distance from an enamel-cementary junction (JAC) to the bottom of the pocket. * In cases where there is gingival recession, the insertion level is complete through the sum of the probing depth value and the gingival recession value (distance from the gingival margin to the JAC). * In cases where the gingival margin coincides with the JAC, the insertion level value is the same as the probing depth. * If there is a pseudo-pocket, characterized by an increase in gingival volume in the coronal direction, the insertion level value will be the result of subtracting the probing depth value and the distance from the gingival margin to the JAC.

  Basline

• Plaque index

  For the evaluation of the plaque index (PI), the PI developed by the authors Ainamo and Bay, in 1975, will be used. It is a dichotomous index, which assesses the presence or absence of bacterial plaque in the cervical area of the tooth in four locations, three locations by vestibular and one location by palatine

  Basline

• Bleeding on probing

  Bleeding on probing is assessed by looking at bleeding points after periodontal probing. It will be evaluated in six locations per tooth, three locations per buccal and three locations per lingual/palatal. A red circle is placed around the sounding depth value (Lang 1986 and 1990).

  Basline

• Gingival Recessions

  Gingival recession will be evaluated in millimeters and is obtained by the distance from the gingival margin to the JAC. It will be evaluated in six locations per tooth, three locations per buccal and three locations per lingual/palatal

  Basline

• Mobility

  Mobility will be assessed with the handle of two instruments (probe and mirror), pushing the tooth in the buccolingual and occlusal-apical directions. The classification proposed by Miller in 1950 will be used, which is divided into: Mobility 0: physiological (0mm to 0.2mm); * Mobility I: \< 1mm in the horizontal direction; * Mobility II: \> 1mm in the horizontal direction; * Mobility III: horizontal and vertical mobility.

  Basline

• Furcation

  The presence of furcation lesions will be evaluated using the Nabers probe. Will be used in the 1975 classification of Hamp * Grade 1 - Loss of horizontal insertion tissue less than 3mm * Grade 2- Loss of horizontal insertion tissue greater than 3mm, but the probe does not it passes from one side to the other. * Grade 3- Loss of horizontal insertion tissue greater than 3mm and the probe passes from side to side

  Basline

Secondary Outcomes (2)

• Microbiological analysis

  Basline

• Inflammatory Mediators

  Basline

Other Outcomes (1)

• Cognitive Assessment

  Basline

Study Arms (2)

Test Group

Adult patients diagnosed with Alzheimer's disease

Diagnostic Test: Periodontal Diagnosis; Diagnostic Test: Microbiological analysis; Diagnostic Test: Inflammatory mediators

Control Group

The control group will consist of patients who attend consultations at the Faculty of Dentistry of the University of Lisbon, matched for age, gender and other confounding factors, such as smoking and systemic diseases (diabetes).

Diagnostic Test: Periodontal Diagnosis; Diagnostic Test: Microbiological analysis; Diagnostic Test: Inflammatory mediators

Interventions

Periodontal Diagnosis DIAGNOSTIC_TEST

All participants, in the test group and in the control group, will undergo an initial periodontal evaluation. The clinical evaluation will always be carried out by the same examiner, the author of the study, in order to guarantee calibrated observations. During data collection, intra-observer calibration will be performed, as recommended by the WHO (WHO, 1993), in order to minimize diagnostic variability and verify agreement

Control Group; Test Group

Microbiological analysis DIAGNOSTIC_TEST

Microbiological analysis will be performed using a sample of subgingival bacterial plaque. The sample will be collected at the tooth and at the location with the highest probing depth values in each quadrant. A sterilized paper tip from the microbiological kit will be introduced to the bottom of the bag, with the aid of tweezers, remaining in the same position for 10 seconds. After collecting the sample, the paper tip will be placed in an individual transfer tube, properly identified. Afterwards, the sample will be sent to the laboratory, where a polymerase chain reaction (PCR) test is performed to identify the following bacteria - A. actinomycetemcomitans, T. forsythia, T. denticola, P. gingivalis, P. intermedia and F. nucleatum.

Control Group; Test Group

Inflammatory mediators DIAGNOSTIC_TEST

The evaluation of inflammatory mediators will be performed with the aid of an absorbent paper strip, which is placed inside the periodontal pocket, for about 30 seconds. The sample will be taken from the tooth that has the highest probing depth values. The collected sample will be placed and stored in an individual transfer tube properly identified and in accordance with the laboratory's instructions. Afterwards, the sample will be sent to the laboratory, where the ELISA test is performed to quantify the following inflammatory mediators - IL-1β, IL-6 and TNF-α.

Control Group; Test Group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

It will be evaluated whether adult patients diagnosed with Alzheimer's Disease have a higher prevalence of Periodontal Disease when compared to adult patients without Alzheimer's Disease. As well, it will be evaluated whether adult patients with different stages of Alzheimer's disease have different stages of severity of Periodontitis. The study sample will be obtained from the Associação Portuguesa de Alzheimer, in the Lisbon region, consisting of adult patients diagnosed with Alzheimer's Disease (test group). The control group sample will consist of patients who attend consultations at the Faculty of Dental Medicine, University of Lisbon, matched for age, gender and other confounding factors, such as tobacco and systemic diseases (diabetes).

You may qualify if:

• Will be included in the study all individuals who attend the Portuguese Alzheimer's Association, diagnosed with Alzheimer's Disease, who:
• have voluntarily given their consent to participate;
• due to cognitive or functional disability, they were unable to give free and informed consent, but they had this consent given by their representative
• individuals who have participated in the cognitive assessment (only for the test group)

You may not qualify if:

• a) refused oral observation.

Sponsors & Collaborators

• University of Lisbon: lead

MeSH Terms

Conditions

Alzheimer Disease; Periodontitis

Condition Hierarchy (Ancestors)

Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Neurocognitive Disorders; Mental Disorders; Periodontal Diseases; Mouth Diseases; Stomatognathic Diseases

Study Officials

• Vanessa Rocha Rodrigues, Dr

  University of Lisbon

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Vanessa Rocha Rodrigues, Dr

CONTACT

919950890; vanessa_15_rodrigues@hotmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 26, 2021
• First Posted: January 12, 2022
• Study Start: September 1, 2022
• Primary Completion: November 1, 2022
• Study Completion: January 1, 2023
• Last Updated: June 24, 2022

Record last verified: 2022-06